Soho Global Health Inkomsten in het verleden
Verleden criteriumcontroles 5/6
Soho Global Health has been growing earnings at an average annual rate of 15.7%, while the Pharmaceuticals industry saw earnings growing at 15.7% annually. Revenues have been growing at an average rate of 11% per year. Soho Global Health's return on equity is 17.1%, and it has net margins of 4.6%.
Belangrijke informatie
15.7%
Groei van de winst
8.0%
Groei van de winst per aandeel
| Pharmaceuticals Groei van de industrie | 20.4% |
| Inkomstengroei | 11.0% |
| Rendement op eigen vermogen | 17.1% |
| Nettomarge | 4.6% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Soho Global Health geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 9,639,926 | 442,787 | 919,801 | 23,157 |
| 30 Jun 24 | 9,119,839 | 443,387 | 871,112 | 20,651 |
| 31 Mar 24 | 8,584,315 | 440,539 | 837,243 | 19,848 |
| 31 Dec 23 | 8,197,755 | 371,341 | 829,867 | 21,060 |
| 30 Sep 23 | 7,913,484 | 338,998 | 830,800 | 20,525 |
| 30 Jun 23 | 7,748,438 | 316,899 | 855,569 | 20,583 |
| 31 Mar 23 | 7,508,390 | 269,516 | 871,507 | 20,382 |
| 31 Dec 22 | 7,290,121 | 356,728 | 856,229 | 20,927 |
| 30 Sep 22 | 6,893,690 | 325,038 | 872,679 | 21,526 |
| 30 Jun 22 | 7,157,590 | 460,676 | 879,389 | 21,206 |
| 31 Mar 22 | 7,288,586 | 563,625 | 879,221 | 22,358 |
| 31 Dec 21 | 7,076,164 | 550,176 | 867,498 | 21,964 |
| 30 Sep 21 | 7,276,332 | 535,489 | 912,459 | 22,050 |
| 30 Jun 21 | 6,528,995 | 227,763 | 1,025,722 | 21,487 |
| 31 Mar 21 | 6,097,286 | 173,734 | 1,024,643 | 19,640 |
| 31 Dec 20 | 6,163,939 | 172,108 | 1,034,383 | 16,900 |
| 30 Sep 20 | 5,805,299 | 193,975 | 924,610 | 16,376 |
| 31 Mar 20 | 5,538,066 | 178,017 | 750,121 | 15,142 |
| 31 Dec 19 | 5,048,301 | 118,457 | 716,750 | 14,723 |
| 31 Dec 18 | 4,563,185 | 49,392 | 658,174 | 13,354 |
| 31 Dec 17 | 4,047,677 | 33,297 | 712,401 | 14,656 |
Kwaliteitswinsten: SOHO has high quality earnings.
Groeiende winstmarge: SOHO's current net profit margins (4.6%) are higher than last year (4.3%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: SOHO's earnings have grown by 15.7% per year over the past 5 years.
Versnelling van de groei: SOHO's earnings growth over the past year (30.6%) exceeds its 5-year average (15.7% per year).
Winst versus industrie: SOHO earnings growth over the past year (30.6%) exceeded the Pharmaceuticals industry 4%.
Rendement op eigen vermogen
Hoge ROE: SOHO's Return on Equity (17.1%) is considered low.